Downregulation of hsa_circ_0005243 may be associated with the pathogenesis of GDM via the regulation of beta-catenin and NF-kappaB signal pathways, suggesting a new potential therapeutic target for GDM.
Downregulation of hsa_circ_0005243 induces trophoblast cell dysfunction and inflammation via the beta-catenin and NF-kappaB pathways.